Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide
Aim: To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. Materials & methods: We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth in vitro was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Conclusion: Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Future medicinal chemistry - 11(2019), 23 vom: 06. Dez., Seite 3005-3013 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Guerrero-Beltrán, Carlos [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-HIV Agents |
---|
Anmerkungen: |
Date Completed 15.07.2020 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.4155/fmc-2018-0539 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30313996X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30313996X | ||
003 | DE-627 | ||
005 | 20231225112213.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4155/fmc-2018-0539 |2 doi | |
028 | 5 | 2 | |a pubmed24n1010.xml |
035 | |a (DE-627)NLM30313996X | ||
035 | |a (NLM)31710246 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Guerrero-Beltrán, Carlos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.07.2020 | ||
500 | |a Date Revised 04.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Aim: To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. Materials & methods: We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth in vitro was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Conclusion: Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a G2-S16 dendrimer | |
650 | 4 | |a HIV-1 | |
650 | 4 | |a dapivirine | |
650 | 4 | |a microbicide | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
650 | 7 | |a Dendrimers |2 NLM | |
650 | 7 | |a Polyelectrolytes |2 NLM | |
650 | 7 | |a Polymers |2 NLM | |
650 | 7 | |a Pyrimidines |2 NLM | |
650 | 7 | |a Silanes |2 NLM | |
650 | 7 | |a carbosilane |2 NLM | |
650 | 7 | |a polyanions |2 NLM | |
650 | 7 | |a Dapivirine |2 NLM | |
650 | 7 | |a TCN4MG2VXS |2 NLM | |
700 | 1 | |a Prieto, AnabeI |e verfasserin |4 aut | |
700 | 1 | |a Leal, Manuel |e verfasserin |4 aut | |
700 | 1 | |a Jiménez, José Luis |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Fernández, M Ángeles |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 11(2019), 23 vom: 06. Dez., Seite 3005-3013 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2019 |g number:23 |g day:06 |g month:12 |g pages:3005-3013 |
856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2018-0539 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2019 |e 23 |b 06 |c 12 |h 3005-3013 |